drugset / Trial / NCT00241904

Reducing Total Cardiovascular Risk in an Urban Community

NCT00241904 ↗

RandomizedParallel-groupOpen-labelPrevention

Summary

PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with a less intensive (LI) intervention - in African American, and white low-income patients with known excessive cardiovascular disease risk.

Timeline

Start
2006-05
Primary completion
2010-05
Completion
2010-05

Outcome

Mixed primary results

registry MEAN Comprehensive Intervention Group: 100.1 (Standard Deviation 39.2) mg/dL NCT00241904 ↗

registry MEAN Less Intensive Intervention Group: 110.6 (Standard Deviation 36.8) mg/dL NCT00241904 ↗

registry analysis (superiority test); Comprehensive Intervention Group vs Less Intensive Intervention Group; p <0.001; General Linear Mixed Model NCT00241904 ↗

registry MEAN Comprehensive Intervention Group: 130.8 (Standard Deviation 20.7) mmHg NCT00241904 ↗

registry MEAN Less Intensive Intervention Group: 135.9 (Standard Deviation 20.5) mmHg NCT00241904 ↗

registry analysis (superiority test); Comprehensive Intervention Group vs Less Intensive Intervention Group; p = 0.003; General Linear Mixed Model NCT00241904 ↗

registry MEAN Comprehensive Intervention Group: 8.3 (Standard Deviation 2.2) percentage of hemoglobin NCT00241904 ↗

registry MEAN Less Intensive Intervention Group: 8.2 (Standard Deviation 2.1) percentage of hemoglobin NCT00241904 ↗

registry analysis (superiority test); Comprehensive Intervention Group vs Less Intensive Intervention Group; p = 0.034; General Linear Mixed Model NCT00241904 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject ACE Inhibitors Unknown — Oral
Subject Aspirin Small molecule 81 mg —
Subject Atenolol Other / unclassified — Oral
Subject Metoprolol Other / unclassified — Oral
Subject Propranolol Small molecule — Oral